Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. The Characterization and Mitigation of Single Event Effects in Ultra-Deep Submicron (< 90nm) Microelectronics

    SBC: Orora Design Technologies, Inc.            Topic: DTRA07005

    Orora Design Technologies proposes to develop electronic design automation (EDA) tools employing minimally invasive circuit design-based methods to mitigate single event effects (SEEs) for next generation Ultra-DSM CMOS (

    SBIR Phase II 2008 Department of DefenseDefense Threat Reduction Agency
  2. Bulk Composite Materials for Detection of Gamma Radiation

    SBC: Tetramer Technologies,L.L.C.            Topic: DTRA08005

    The objective of this proposal is to develop enabling technology for the production of bulk scintillating nanocomposites that have gamma radiation detection properties of single crystal NaI but with the manufacturability of plastic scintillators. These performance criteria may be met by developing nanoparticle polymer composites with ultra-high nanoparticle loadings. These ‘ultra-composites’ w ...

    SBIR Phase I 2008 Department of DefenseDefense Threat Reduction Agency
  3. Portable Time of Flight Mass Spectrometer for Nuclear Forensics

    SBC: CREARE LLC            Topic: DTRA08004

    Analysis of nuclear material samples in the field has many advantages over laboratory analysis. Laboratory analyses can be slow, involve increased expense, lead to additional waste generation and disposal problems, and may introduce errors due to sample degradation or mishandling. In situ analysis mitigates all of these problems. The specific aim of this project is the development of a truly por ...

    SBIR Phase I 2008 Department of DefenseDefense Threat Reduction Agency
  4. Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide

    SBC: ACCIUM BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): It is widely accepted that the existing clinical paradigm of one treatment fits all is a major factor in the lack of progress in the effective treatment of a highly heterogeneous diseases. We propose a new innovative cl inical paradigm that optimizes brain cancer therapy using patient-specific markers of therapeutic response. Our long-term objective is to impro ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Optical nerve stimulation for a vestibular prosthesis

    SBC: Aculight Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Vestibular disorders represent a debilitating medical problem by causing balance and vision impairments that adversely affects the lives of people of all ages and backgrounds. The restoration of vestibular function by d irect stimulation of the vestibular nerve, bypassing the sensory organs, is expected to alleviate these symptoms in some patients. Currently, t ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. IMPROVED DIAGNOSTIC INFRARED NERVE STIMULATOR FOR ENT NERVE MONITORING

    SBC: Aculight Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Iatrogenic nerve damage is one of the most adverse sequalae of tumor resection surgery in all parts of the body. Many neuromonitoring techniques have been developed to lower the incidence of damage, most notably electr ostimulation. However, the clinical potential of precise neuromonitoring remains unfulfilled, due to several key limitations intrinsic to elect ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. Peptide-Modified Sulfonated Styrene Block Copolymers for Vascular Applications

    SBC: AEGIS BIOSCIENCES, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): A novel sulfonated polymer with unique chemically tailorable properties and processing characteristics has shown considerable promise as a thrombo- resistant surface and has been proven to be effective inhibitor against neutrophil- derived proteases. A phase 1 SBIR testing is proposed to investigate this polymer as a tailorable interface coating for blood-cont ...

    SBIR Phase I 2008 Department of Health and Human Services
  8. Integrating microbial signal transduction pathways and their metabolic targets

    SBC: AGILE GENOMICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Signal transduction systems regulate the majority of cellular activities including the metabolism, development, host-recognition, biofilm production, virulence, and antibiotic resistance of human pathogens. Thus, knowle dge of the proteins and interactions that comprise these communication networks is an essential component to furthering biomedical discovery. T ...

    SBIR Phase I 2008 Department of Health and Human Services
  9. MICROWAVE REMEDIATION OF HAZARDOUS MEDICAL WASTES

    SBC: Ashwin-Ushas Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): This project proposes to build and test a 20 L capacity Remediator for medical wastes. Infectious Medical Wastes (IMW), mainly from hospitals, represents a major component of hazardous wastes generated in the U.S.. In f act, more than 4.5 million tons are generated per year. Hospital waste remediation was a 1.5 billion industry in 2003. Incineration remains th ...

    SBIR Phase II 2008 Department of Health and Human Services
  10. THE PURPOSE OF THIS GRANT IS TO SELECT APPROVABLE DRUGS FOR THE TREATMENT OF FOUR ORPHAN DISEASES: SICKLE CELL DISEASE,THALASSEMIA, HEMOCHROMATOSIS, AND ERYTHROPOIETIC PORPHYRIAS.

    SBC: Atmospheric Health Sciences            Topic: N/A

    THE PURPOSE OF THIS GRANT IS TO SELECT APPROVABLE DRUGS FOR THE TREATMENT OF FOUR ORPHAN DISEASES: SICKLE CELL DISEASE,THALASSEMIA, HEMOCHROMATOSIS, AND ERYTHROPOIETIC PORPHYRIAS.FROM THE AVAILABLE WORLD MEDICAL LITERATURE ON THE FOUR DISEASES, DRUGS THAT ARE CLAIMED TO BE EFFECTIVE WILL BE EVALUATED AND CATEGORIZED AS TO THE EXTENT OF CLINICAL TESTING AND ANIMAL EXPERIMENTATION. THE THERAPEUTIC R ...

    SBIR Phase I 1983 Department of Health and Human Services
US Flag An Official Website of the United States Government